top of page
What Stands Out With the M10 Guidance?
Chris Tudan

Veloxity Director of Quality Assurance, Christopher Tudan, PhD., spoke about the differences between the recently adopted M10 Guidance compared to the past EMA and FDA Guidances on Bioanalytical Method Validation and Sample Analysis during the November 1 AAPS eChalk Talks, at 11:15am EDT.



Please complete the form below to receive a copy of the presentation

Christopher Tudan, PhD.
Director of Quality Assurance

What Stands Out With the M10 Guidance?

bottom of page